Cargando…

Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria

Hepatitis C virus (HCV) is an important health care problem in haemodialysis. Hepatitis C virus is both a cause and complication of kidney diseases. Yet there are limited information on antibody against HCV in patients on haemodialysis. The purpose of this study was to determine the prevalence of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ummate, Ibrahim, Denue, Ballah Akawu, Kida, Ibrahim Musa, Ohioma, Onah Joseph, Baba, David Bukbuk, Goni, Waru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393967/
https://www.ncbi.nlm.nih.gov/pubmed/25883732
http://dx.doi.org/10.11604/pamj.2014.19.305.5639
_version_ 1782366238162288640
author Ummate, Ibrahim
Denue, Ballah Akawu
Kida, Ibrahim Musa
Ohioma, Onah Joseph
Baba, David Bukbuk
Goni, Waru
author_facet Ummate, Ibrahim
Denue, Ballah Akawu
Kida, Ibrahim Musa
Ohioma, Onah Joseph
Baba, David Bukbuk
Goni, Waru
author_sort Ummate, Ibrahim
collection PubMed
description Hepatitis C virus (HCV) is an important health care problem in haemodialysis. Hepatitis C virus is both a cause and complication of kidney diseases. Yet there are limited information on antibody against HCV in patients on haemodialysis. The purpose of this study was to determine the prevalence of anti-HCV and the risk factors associated with HCV infection in a cohort of 100 participants on haemodialysis. They were consecutively recruited into the study, anti-HCV testing was made by the 3rd-generation ELISA System (C-100, C-33c, C-22). The prevalence of HCV antibody was 15%, risk factors associated with HCV antibody were history of blood transfusion and duration of session of haemodialysis; the risk increased with increased with the number of blood transfusion and seasons of haemodialysis. The observed high prevalence of HCV antibody among patients on haemodialysis reflect the quality of healthcare services and the standards of infection control practices in our haemodialysis units. Routine screening for HCV should be done before blood transfusion using third generation ELISA assays with high sensitivity and specificity. Safety measures should be taken in our haemodialysis units to prevent cross infection among patients and staffs. These safety measures include; discarding syringes, needles, gloves, bloodlines and dialysers after single use, and the use of sterile dressings on each patient visit.
format Online
Article
Text
id pubmed-4393967
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-43939672015-04-16 Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria Ummate, Ibrahim Denue, Ballah Akawu Kida, Ibrahim Musa Ohioma, Onah Joseph Baba, David Bukbuk Goni, Waru Pan Afr Med J Short Communication Hepatitis C virus (HCV) is an important health care problem in haemodialysis. Hepatitis C virus is both a cause and complication of kidney diseases. Yet there are limited information on antibody against HCV in patients on haemodialysis. The purpose of this study was to determine the prevalence of anti-HCV and the risk factors associated with HCV infection in a cohort of 100 participants on haemodialysis. They were consecutively recruited into the study, anti-HCV testing was made by the 3rd-generation ELISA System (C-100, C-33c, C-22). The prevalence of HCV antibody was 15%, risk factors associated with HCV antibody were history of blood transfusion and duration of session of haemodialysis; the risk increased with increased with the number of blood transfusion and seasons of haemodialysis. The observed high prevalence of HCV antibody among patients on haemodialysis reflect the quality of healthcare services and the standards of infection control practices in our haemodialysis units. Routine screening for HCV should be done before blood transfusion using third generation ELISA assays with high sensitivity and specificity. Safety measures should be taken in our haemodialysis units to prevent cross infection among patients and staffs. These safety measures include; discarding syringes, needles, gloves, bloodlines and dialysers after single use, and the use of sterile dressings on each patient visit. The African Field Epidemiology Network 2014-11-21 /pmc/articles/PMC4393967/ /pubmed/25883732 http://dx.doi.org/10.11604/pamj.2014.19.305.5639 Text en © Ballah Akawu Denue et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Ummate, Ibrahim
Denue, Ballah Akawu
Kida, Ibrahim Musa
Ohioma, Onah Joseph
Baba, David Bukbuk
Goni, Waru
Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria
title Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria
title_full Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria
title_fullStr Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria
title_full_unstemmed Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria
title_short Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at Kidney Centre in a tertiary health facility in Maiduguri, Nigeria
title_sort risk factors for hepatitis c virus sero-positivity among haemodialysis patients receiving care at kidney centre in a tertiary health facility in maiduguri, nigeria
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393967/
https://www.ncbi.nlm.nih.gov/pubmed/25883732
http://dx.doi.org/10.11604/pamj.2014.19.305.5639
work_keys_str_mv AT ummateibrahim riskfactorsforhepatitiscvirusseropositivityamonghaemodialysispatientsreceivingcareatkidneycentreinatertiaryhealthfacilityinmaidugurinigeria
AT denueballahakawu riskfactorsforhepatitiscvirusseropositivityamonghaemodialysispatientsreceivingcareatkidneycentreinatertiaryhealthfacilityinmaidugurinigeria
AT kidaibrahimmusa riskfactorsforhepatitiscvirusseropositivityamonghaemodialysispatientsreceivingcareatkidneycentreinatertiaryhealthfacilityinmaidugurinigeria
AT ohiomaonahjoseph riskfactorsforhepatitiscvirusseropositivityamonghaemodialysispatientsreceivingcareatkidneycentreinatertiaryhealthfacilityinmaidugurinigeria
AT babadavidbukbuk riskfactorsforhepatitiscvirusseropositivityamonghaemodialysispatientsreceivingcareatkidneycentreinatertiaryhealthfacilityinmaidugurinigeria
AT goniwaru riskfactorsforhepatitiscvirusseropositivityamonghaemodialysispatientsreceivingcareatkidneycentreinatertiaryhealthfacilityinmaidugurinigeria